Scribd Logo
Upload

Welcome to Scribd!

  • Img 0153

    Uploaded by

    Lân Vũ
    4 views1 page
    The Ministry of Science and Technology in China declared Favilavir, chloroquine phosphate, and remdesivir as potential antiviral drugs for treating COVID-19. A clinical trial found that only Favilavir was effective against the novel coronavirus, while the other two drugs were effective for treating malaria. Additionally, studies in the US showed that remdesivir helped treat MERS, a related coronavirus, and it was used to treat COVID-19 patients there. There is also a proposal to use the protease inhibitor combination of lopinavir-ritonavir to treat COVID-19.

    Original Description:

    Original Title

    IMG_0153

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The Ministry of Science and Technology in China declared Favilavir, chloroquine phosphate, and remdesivir as potential antiviral drugs for treating COVID-19. A clinical trial found that only Favilavir was effective against the novel coronavirus, while the other two drugs were effective for treating malaria. Additionally, studies in the US showed that remdesivir helped treat MERS, a related coronavirus, and it was used to treat COVID-19 patients there. There is also a proposal to use the protease inhibitor combination of lopinavir-ritonavir to treat COVID-19.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    4 views1 page

    Img 0153

    Uploaded by

    Lân Vũ
    The Ministry of Science and Technology in China declared Favilavir, chloroquine phosphate, and remdesivir as potential antiviral drugs for treating COVID-19. A clinical trial found that only Favilavir was effective against the novel coronavirus, while the other two drugs were effective for treating malaria. Additionally, studies in the US showed that remdesivir helped treat MERS, a related coronavirus, and it was used to treat COVID-19 patients there. There is also a proposal to use the protease inhibitor combination of lopinavir-ritonavir to treat COVID-19.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    14 ANTIVIRAL THERAPY

    COVID-19 is an infectious disease caused by SARS-COV-2, which is also termed


    the novel coronavirus and is diligently associated with the SARS virus. The
    Ministry of Science and Technology from the People's Republic of China declared
    three potential antiviral medicines suitable for treating COVID-19. Those three
    medicines are, namely, Favilavir, chloroquine phosphate and remdesivir. A clinical
    trial was conducted to test the efficacy of those three drugs, and the results proved
    that out of the three medicines above only Favilavir is effective in treating the
    patients with novel coronavirus. The remaining two drugs were effective in
    treating malaria.62
    Likewise a study carried out in the United States by the National Institute of Health
    proved that remdesivir is effective in treating the Middle East respiratory syndrome
    coronavirus (MERSCoV), which is also a type of coronavirus that was transmitted
    from monkeys. The drug remdesivir was also used in the United States for treating
    the patients with COVID-19. There has been a proposal to use the combination of
    protease inhibitors lopinavir-ritonavir for treating the patients affected by COVID-
    19.62

    You might also like